- Home
- RRGB vs MOLN Comparison
RRGB vs MOLN Comparison
Compare RRGB & MOLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RRGB | MOLN |
|---|---|---|
| Founded | 1969 | 2004 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Restaurants | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 142.9M | 170.5M |
| IPO Year | 2002 | 2021 |
Fundamental Metrics
Financial Performance| Metric | RRGB | MOLN |
|---|---|---|
| Price | $7.08 | $4.21 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $9.00 | $8.38 |
| AVG Volume (30 Days) | ★ 275.4K | 1.5K |
| Earning Date | 05-28-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 73.43 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,315,014,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $374.07 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.46 | $3.53 |
| 52 Week High | $10.95 | $5.36 |
Technical Indicators
Market Signals| Indicator | RRGB | MOLN |
|---|---|---|
| Relative Strength Index (RSI) | 35.94 | 50.27 |
| Support Level | $6.26 | $4.13 |
| Resistance Level | $7.36 | $4.21 |
| Average True Range (ATR) | 0.44 | 0.15 |
| MACD | -0.21 | -0.04 |
| Stochastic Oscillator | 9.10 | 42.05 |
Price Performance
Historical ComparisonAbout RRGB Red Robin Gourmet Burgers Inc.
Red Robin Gourmet Burgers Inc is a restaurant operator. The company develops, operates, and franchises casual-dining restaurants and fast-casual restaurants in North America. The company's brands are Red Robin, Red Robin Gourmet Burgers, Red Robin America's Gourmet Burgers and Spirits, Red Robin Burger Works, YUMMM, Red Robin Gourmet Burgers and Brews, and Red Robin Royalty names and logos. The company's revenue consists of sales from restaurant operations, gift card breakage, franchise royalties and fees, and other miscellaneous revenue. It has one operating and one reportable segment: restaurants.
About MOLN Molecular Partners AG
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company is currently focusing on oncology through their robust pipeline of clinical and preclinical programs, with particular attention to MP0712, the key Radio-DARPin candidate targeting DLL3 now in a Phase 1/2a trial in the United States.